Carbidopa and Levodopa
NDC 16571-159, carbidopa and levodopa, tablet, orally disintegrating, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-159
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078893
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-159 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARBIDOPA25 mg/1
- LEVODOPA250 mg/1
Pharmacologic classes
Amino Acids, Aromatic [CS]; Aromatic Amino Acid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-159-01 | 16571015901 | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (16571-159-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/302bfe03-d222-4a87-80ff-f2dbfb9a07f4NADAC price for package 16571015901
GET /v1/drugs/nadac/16571015901
Use it
Look up 16571-159 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-159 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-159. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.